Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride caused long-term sexual and non-sexual side effects in young men with hair loss.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

Testosterone replacement therapy can prevent men from fathering children and should not be used by those wanting to stay fertile.

Dermoscopy has improved skin cancer diagnosis and has expanding applications in dermatology, but requires staying updated with new research and techniques.

Bimatoprost is promising for treating some types of hair loss but needs more testing for androgenetic alopecia.

Bimatoprost was found to be safer and more effective than mometasone furoate for treating scalp hair loss.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

The study concluded that scalp tumors show different patterns based on age, gender, and tumor thickness, and emphasized the importance of early detection and scalp examinations.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Prostaglandin F2α analogs show promise for treating certain types of hair loss but need more research for other skin conditions.

MALDI Imaging Mass Spectrometry is a useful method for studying skin conditions, but sample preparation is crucial for accurate results.

Continuous light exposure in rats leads to PCOS-like symptoms and suggests sleep habits might affect the disorder's development.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Eyebrow loss has many causes and requires accurate diagnosis for proper treatment.

3D-printed mesoporous scaffolds show promise for personalized drug delivery with controlled release.

Nanomaterials in biomedicine can improve treatments but may have risks like toxicity, needing more safety research.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

Post-finasteride syndrome causes lasting sexual, neurological, and physical side effects in some people after taking finasteride.

Researchers created better skin-application menthol capsules that are stable, safe, and penetrate the skin quickly.

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Finasteride reduces response to stress and rewards, affecting behavior and mental health.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Melatonin-loaded nanocarriers improve melatonin delivery and effectiveness for various medical treatments.

Post-finasteride patients show changes in gut bacteria, possibly causing various symptoms.

The PS-b-PAA copolymer nanomicelles are effective for delivering a cancer treatment drug in photodynamic therapy.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

α-Blockers and 5-ARIs for BPH can cause sexual dysfunction, including erectile and ejaculatory issues.